Alamar Biosciences develops technologies for the detection and treatment of cancer and other diseases at the earliest possible time. The company was founded in 2018 and is headquartered in Fremont, California.
Alamar BiosciencesCSLGrowingDataSydney Neuroimaging Analysis CentreUniversity of SydneyTabcorpUniversity of SydneyEastern Washington UniversityUniversity of California BerkeleyUniversity of Science and Technology of China
Yiyuan Yin
Researcher
Alamar BiosciencesNGM BiopharmaceuticalsGenentechUniversity of MarylandFudan UniversityUniversity of Maryland
Steve Chen
COO at Alamar Biosciences
Alamar BiosciencesBio-TechneAdvanced Cell DiagnosticsPower Automation SystemsPanomicsUniversity of MarylandUniversity of LondonZhejiang UniversityUniversity of Science and Technology of China